A regularly updated video series answering a selection of frequently asked investor questions
January 27, 2020
Dry AMD Competitive Landscape Overview & OpRegen Positioning
January 9, 2020
VAC2 Program & Research Partnership with CRUK
December 31, 2019
Review of cost efficient business model & plans for 2020
December 17, 2019
Review of recent results from OpRegen Phase I/IIa study
Key opinion leaders discuss topics related to Lineage’s clinical programs
OpRegen® Phase 1/2a Clinical Study Results
2020 ARVO Meeting
Christopher D. Riemann, M.D., Cincinnati Eye Institute (CEI)
Why is dry age-related macular degeneration (dry AMD) research so important?
Allen C. Ho, M.D., Wills Eye Hospital Director of Retina Research
Why is spinal cord research so important?
Dr. John Steeves, Emeritus Principal Investigator @ICORD and Professor @UBC
Presentations from specific events, conferences, or showcases
NobleCon16 Investor Conference Webcast
H.C.Wainwright & Co. Annual Global Investment Conference
Lumiseek: The Cancer Impact Network Podcast
Dr. Bindu, CEO Lumiseek, interviews our CEO Brian Culley – Apr. 3rd, 2020
Solebury Trout Talks
Lineage Cell CEO encouraged about its dry AMD data
CEO Brian Culley chats with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco
A selection of patient focused media related to our cell therapy programs
5 years through the eyes of a mum.
A powerful dramatization of living with the progression of vision loss related to AMD. Source: www.macularsociety.org
Lucas Lindner was paralyzed from the neck down following a car accident. The next year, he threw out the first pitch at a Major League Baseball game.
Watch the video above to learn more about Lucas’ journey.